Type I Diabetes News and Research

RSS

Obese teenagers face higher metabolic syndrome risk in South America than Europe

Obese teenagers are much more likely to suffer from metabolic syndrome - which can lead to heart disease - if they live in Brazil than Italy, according to a study in the October issue of IJCP, the International Journal of Clinical Practice.

13 Oct 2008

Experts say more exercise and better diet the key to childhood obesity

With experts saying the life expectancy of Australian children will be shortened by two years if something is not done about the country's obesity epidemic, researchers in Britain are saying the one hour of moderate exercise a day recommended to children from health experts may not be enough to tackle the problem of childhood obesity.

13 Oct 2008

FDA continues review of Takeda's NDA for Alogliptin

Takeda Pharmaceutical Company Limited has announced that Takeda Global Research and Development Center, Inc., a wholly owned United States (U.S.) subsidiary, received notification that the U.S. Food and Drug Administration (FDA) will not be able to complete its review of the alogliptin New Drug Application (NDA) by the Prescription Drug User Fee Act (PDUFA) date of October 27, 2008.

12 Oct 2008

School vending machines dole out excess calories and added sugar beverages

Despite efforts to include more healthy choices at schools, standard offerings from vending machines - including fruit juices - are giving students more calories than they need.

6 Oct 2008

Too many Australian children have an unhealthy lifestyle

A survey on the lifestyle of Australian children has found big changes need to be made if many are to avoid health problems later on in life.

6 Oct 2008

Will patients stick to physical therapy? Questionnaire can help doctors predict

Patients' responses to a simple questionnaire can reliably predict whether they will adhere to physical therapy after spine surgery, Johns Hopkins researchers suggest in a new study. The findings could help physicians identify patients who might benefit from additional preoperative preparation to ensure they attend therapy sessions and follow through with prescribed exercise, a factor that can greatly affect their long-term recovery.

2 Oct 2008

Array BioPharma presents positive data on its glucokinase activators in type 2 diabetes

Array BioPharma Inc. has announced the presentation of preclinical data on a novel small molecule glucokinase activator (GKA), ARRY-403, a drug for the treatment of Type 2 diabetes.

25 Sep 2008

Discovery offers new understanding of diabetes drug target

Scientists at the University of Leicester have published findings about a new advance in the study of major diabetes drug target.

25 Sep 2008

Major study aims for new approaches to cardiovascular disease management

The Consortium for Southeastern Hypertension Control (COSEHC), headquartered at Wake Forest University Baptist Medical Center, is launching a major five-year study designed to update current guidelines for treating cardiovascular diseases, improve disease management and reduce heart attacks and strokes in the Southeast.

24 Sep 2008

Exposure to bacteria might prevent type I diabetes

Researchers from Yale University and the University of Chicago have found a startling illustration of the potential for microbes to prevent disease - they found that mice exposed to common stomach bacteria were protected against the development of type I diabetes.

22 Sep 2008

New research puts FDA under pressure over BPA

The results of a new study which has linked a chemical commonly used to make plastic containers, to human diseases, is adding to an already heated debate about he safety of such products.

17 Sep 2008

Men's health campaign launched to address often overlooked physical, emotional and sexual issues affecting men with diabetes

In addition to dealing with the day-to-day aspects of diabetes management that involve blood glucose, nutrition and lifestyle management, men in the United States with diabetes are also grappling with other physical, emotional and sexual health issues according to survey findings released today by the American Diabetes Association.

9 Sep 2008

New treatment for diabetics identified

Some of the most serious health complications associated with diabetes could be prevented or delayed by taking a widely available cholesterol-lowering drug which has already been on the market for three decades, new research has shown.

8 Sep 2008

Once a week treatment for type 2 diabetes in the pipeline

Canadian researchers have found that a weekly treatment for type 2 diabetes has proved safe and effective for patients.

8 Sep 2008

Natural birth better for bonding baby and mother

American researchers are suggesting that natural birth may make mothers more responsive to their babies than those who choose to have a Caesarean.

4 Sep 2008

Monitoring immune responses in disease

A recent study published in Clinical Immunology, the official journal of the Clinical Immunology Society (CIS), describes a new method enabling the detection of multiple parameters of single human cells.

3 Sep 2008

Advances in cell therapy bring cure for diabetes step closer

Affecting eight percent of America's population, diabetes can lead to blindness, kidney failure, strokes and heart disease. Thanks to Tel Aviv University researchers, a new cure -- based on advances in cell therapy -- may be within reach.

2 Sep 2008

Advances in the management of diabetes mellitus

The need for long term studies to establish the best means of treating Diabetes, was underlined by Prof John Cleland from the University of Hull at the ESC Congress in Munich. Prof Cleland listed the latest treatment available for patients and voiced his concern about the side-effects and efficacy of available anti-diabetic drugs.

1 Sep 2008

Primary prevention of coronary heart disease: challenges and achievements

The European Society of Cardiology together with other partner Societies has engaged in a comprehensive programme of prevention of cardiovascular disease (CVD) since 1994. Guidelines on this important topic have been developed and updated at regular intervals over the last 13 years, most recently in 2007.

1 Sep 2008

Thiazolidinediones - diabetes drugs carry significant cardiovascular risks

A class of oral drugs used to treat type 2 diabetes may significantly increase the risk of serious cardiovascular events, according to an editorial published online in Heart Wednesday by two Wake Forest University School of Medicine faculty members.

28 Aug 2008